NCT04435821View on ClinicalTrials.gov

PET/MRI in the Diagnosis of Pediatric Chronic Pain

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

November 19, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

October 31, 2024

Conditions
Chronic PainPediatric DisorderNeuropathic PainNociceptive Pain
Interventions
DRUG

[18F]FTC-146

Participants will be injected with 0.08 mCi/kg \[18F\]FTC-146. A whole-body PET/MRI scan will be performed after injection.

Trial Locations (1)

94305

Stanford University, Stanford

Sponsors

Collaborators (1)

GE Healthcare
All Listed Sponsors
collaborator

GE Healthcare

INDUSTRY

lead

Stanford University

OTHER